Company

OphtiMed Rx

Biotechnology Research Katzrin, Il 4 employees

Employees: 4
Contacts: 1
Emails: 1
Phones: 1

www.ophtimedrx.com LinkedIn

OphtiMed Rx Overview

Headquarters: Katzrin, Il
Website: www.ophtimedrx.com
Industry: Biotechnology Research
Employees: 4
Founded: 2021
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About OphtiMed Rx

OphtiMed Rx LTD is a preclinical ophthalmic drug development company led by experts in ophthalmology, molecular biology, biotech, out-licensing, and M&As. The company is developing a novel molecular therapy for dry Age-related Macular Degeneration (AMD), a leading cause of blindness affecting millions worldwide. Yet, no effective treatments exist to prevent retinal damage and vision loss. Our drug targets the aging process (cellular senescence) that underlies AMD, offering a transformative solution to halt the disease in its early stages and preserve vision. Our cutting-edge therapy will prevent the loss of vision and independence and bring enormous benefits to patients.

OphtiMed Rx Contact Details

People in AeroLeads: 3
With contact data: 1
Email contacts: 1; 33.3% coverage
Phone contacts: 1; 33.3% coverage

OphtiMed Rx Org Chart

Sample employees and titles

Name	Title	Location	Contact
Dana Rabinovich	Biotech Executive & Entrepreneur - R&D		View
Ayala Pollack	Retina Specialist, Researcher	Israel	View
Luis Iglesias	Chairman, Board Member, Strategic	United Kingdom	Email Phone